Advanced HF No Obstacle to AF Ablation Success: CASTLE-HTx

This 'should help eradicate the current somewhat nihilistic approach' to managing atrial fibrillation in advanced heart failure, said an expert.

Related Keywords

Germany ,Amsterdam ,Noord Holland ,Netherlands ,Boston ,Massachusetts ,United States ,Denmark ,Bad Oeynhausen ,Nordrhein Westfalen ,Astra Zeneca ,Philipp Sommer ,Finn Gustafsson ,Christian Sohns ,Alnylam Amgen ,Biosense Webster ,Baim Institute For Clinical Research ,Diabetes Center North Rhine Westphalia ,Medtronic ,European Society Of Cardiology Congress ,Pfizer ,Corvia Research ,Boehringer Ingelheim ,European Society Of Cardiology ,Rigshopsitalet Copenhagen University Hospital ,Boston Scientific ,Novartis ,European Society ,New England Journal ,Advanced Heart Disease ,Broadview Ventures ,Baim Institute ,Clinical Research ,Cardiology Congress ,Hot Line ,Atrial Fibrillation ,F Atrial Fibrillation ,Heart Failure ,Cardiomyopathy ,Heart ,End Stage Organ Disease ,Tablation ,Transplantation Heart ,Cardiac Transplantation ,Ransplantation Cardiac ,Heart Transplantation ,Catheter Ablation ,Transplantation ,Transplant ,Hospitals ,Clinical Trials ,Linical Studies ,Ventricular Assist Device ,Echanical Cardiac Assist ,Echanical Cardiac Suppo ,